These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21475842)

  • 1. Evaluation of the individual 50% inhibitory area under the concentration curve of 5-fluorouracil based on the collagen gel droplet embedded culture drug sensitivity test in colorectal cancer.
    Ochiai T; Nishimura K; Watanabe T; Kitajima M; Tsuji M; Nakatani A; Nakayama N; Marusasa T; Mashiko S; Nagaoka I; Futagawa S
    Mol Med Rep; 2009; 2(3):405-9. PubMed ID: 21475842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 5-fluorouracil applicability by the collagen gel droplet embedded drug sensitivity test with area under the curve analysis.
    Ochiai T; Nishimura K; Noguchi H; Watanabe T; Kitajima M; Konishi N; Sato G; Nagaoka I; Futagawa S
    Anticancer Drugs; 2007 Jan; 18(1):17-21. PubMed ID: 17159498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of responders/non-responders to 5-fluorouracil based on individual 50% inhibitory area under the concentration curve of 5-fluorouracil obtained with collagen gel droplet-embedded culture-drug sensitivity test in colorectal cancer.
    Ochiai T; Nishimura K; Watanabe T; Kitajima M; Nakatani A; Marusasa T; Hashiguchi T; Uchida T; Sakuyama N; Sato T; Kishine K; Futagawa S; Nagaoka I
    Oncol Lett; 2011 Mar; 2(2):309-313. PubMed ID: 22866082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 5-fluorouracil applicability by multi-point collagen gel droplet embedded drug sensitivity test.
    Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsuruoka Y; Takahashi Y
    Oncol Rep; 2005 Jul; 14(1):201-5. PubMed ID: 15944790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test.
    Ochiai T; Nishimura K; Watanabe T; Kitajima M; Nakatani A; Nagayasu K; Naito S; Sato T; Kishine K; Abe Y; Hara C; Yamada S; Mashiko S; Nagaoka I
    Oncol Lett; 2017 Nov; 14(5):6045-6052. PubMed ID: 29113244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takami K; Morinaga K; Takano T; Kobayashi H
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):355-62. PubMed ID: 19131921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized chemotherapy for colorectal cancer based on the collagen gel droplet-embedded drug sensitivity test.
    Ochiai T; Nishimura K; Watanabe T; Kitajima M; Nakatani A; Inou T; Washio M; Sakuyama N; Sato T; Kishine K; Ochi T; Okubo S; Futagawa S; Mashiko S; Nagaoka I
    Oncol Lett; 2012 Oct; 4(4):621-624. PubMed ID: 23205073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Kihara A; Okano M
    Gan To Kagaku Ryoho; 2001 May; 28(5):661-7. PubMed ID: 11383215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
    Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
    Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study to predict optimal duration of chemotherapy with fluoropyrimidine by multi-point collagen gel droplet embedded drug sensitivity test.
    Tokunaga Y; Sasaki H; Ohnishi T
    Hepatogastroenterology; 2010; 57(104):1390-4. PubMed ID: 21443091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy.
    Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsuruoka Y; Takahashi Y; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
    J Surg Oncol; 2006 Jul; 94(1):45-50. PubMed ID: 16788943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer.
    Oi K; Makino M; Ozaki M; Takemoto H; Yamane N; Nakamura S; Ikeguchi M; Kaibara N
    Anticancer Res; 2004; 24(1):273-9. PubMed ID: 15015608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan as individualized first-line therapy based on a drug sensitivity test.
    Ochiai T; Nishimura K; Watanabe T; Kitajima M; Hashiguchi T; Nakatani A; Marusasa T; Muraki A; Nagaoka I; Futagawa S
    Exp Ther Med; 2010 Mar; 1(2):325-329. PubMed ID: 22993545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishing the method of collagen-gel droplet embedded culture drug sensitivity test with rat tail collagen].
    Hu Y; Zhou T; Liao Q; Zhang TP; Chen G; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):998-1001. PubMed ID: 19035202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
    Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
    Di Paolo A; Lencioni M; Amatori F; Di Donato S; Bocci G; Orlandini C; Lastella M; Federici F; Iannopollo M; Falcone A; Ricci S; Del Tacca M; Danesi R
    Clin Cancer Res; 2008 May; 14(9):2749-55. PubMed ID: 18451241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Imamura F; Minamikawa K; Takano T; Kobayashi H
    Lung Cancer; 2010 Jun; 68(3):472-7. PubMed ID: 19660825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.